These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8255079)

  • 21. Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo.
    Tsuruo T; Matsuzaki T; Matsushita M; Saito H; Yokokura T
    Cancer Chemother Pharmacol; 1988; 21(1):71-4. PubMed ID: 3342468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative analysis of DNA topoisomerase I activity in human and rat glioma: characterization and mechanism of resistance to antitopoisomerase chemical, camptothecin-11.
    Matsumoto Y; Fujiwara T; Honjo Y; Sasaoka N; Tsuchida T; Nagao S
    J Surg Oncol; 1993 Jun; 53(2):97-103. PubMed ID: 8388965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: lack of cross-resistance in vivo in tumors with acquired resistance to the topoisomerase I inhibitor 9-dimethylaminomethyl-10-hydroxycamptothecin.
    Houghton PJ; Cheshire PJ; Hallman JC; Bissery MC; Mathieu-Boué A; Houghton JA
    Cancer Res; 1993 Jun; 53(12):2823-9. PubMed ID: 8504425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of water soluble poly(L-glutamic acid)-camptothecin conjugate against resistant human lung cancer xenografted in nude mice.
    Zou Y; Wu QP; Tansey W; Chow D; Hung MC; Charnsangavej C; Wallace S; Li C
    Int J Oncol; 2001 Feb; 18(2):331-6. PubMed ID: 11172600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft model.
    Britten CD; Hilsenbeck SG; Eckhardt SG; Marty J; Mangold G; MacDonald JR; Rowinsky EK; Von Hoff DD; Weitman S
    Cancer Res; 1999 Mar; 59(5):1049-53. PubMed ID: 10070962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New highly lipophilic camptothecin BNP1350 is an effective drug in experimental human cancer.
    Van Hattum AH; Pinedo HM; Schlüper HM; Hausheer FH; Boven E
    Int J Cancer; 2000 Oct; 88(2):260-6. PubMed ID: 11004678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting molecular pathways with camptothecin as novel therapy for gastric cancer.
    Litvak DA; Papaconstantinou HT; Evers BM; Townsend CM
    J Gastrointest Surg; 1999; 3(6):618-24. PubMed ID: 10554369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Camptothecin delivery systems: enhanced efficacy and tumor accumulation of camptothecin following its conjugation to polyethylene glycol via a glycine linker.
    Conover CD; Greenwald RB; Pendri A; Gilbert CW; Shum KL
    Cancer Chemother Pharmacol; 1998; 42(5):407-14. PubMed ID: 9771956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of the efficacy and pharmacology of irinotecan against human colon tumor xenograft models.
    Zamboni WC; Stewart CF; Cheshire PJ; Richmond LB; Hanna SK; Luo X; Poquette C; McGovren JP; Houghton JA; Houghton PJ
    Clin Cancer Res; 1998 Mar; 4(3):743-53. PubMed ID: 9533544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic agents active against mucinous adenocarcinoma of the ovary.
    Shimizu Y; Nagata H; Kikuchi Y; Umezawa S; Hasumi K; Yokokura T
    Oncol Rep; 1998; 5(1):99-101. PubMed ID: 9458301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts.
    Castellino RC; Elion GB; Keir ST; Houghton PJ; Johnson SP; Bigner DD; Friedman HS
    Cancer Chemother Pharmacol; 2000; 45(4):345-9. PubMed ID: 10755324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograft.
    Patel VJ; Elion GB; Houghton PJ; Keir S; Pegg AE; Johnson SP; Dolan ME; Bigner DD; Friedman HS
    Clin Cancer Res; 2000 Oct; 6(10):4154-7. PubMed ID: 11051270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic activity of 7-[(2-trimethylsilyl)ethyl)]-20 (S)-camptothecin against central nervous system tumor-derived xenografts in athymic mice.
    Keir ST; Hausheer F; Lawless AA; Bigner DD; Friedman HS
    Cancer Chemother Pharmacol; 2001 Jul; 48(1):83-7. PubMed ID: 11488529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of carboxylesterase inhibition on the anti-tumour effects of irinotecan.
    Morishita Y; Fujii M; Kasakura Y; Takayama T
    J Int Med Res; 2005; 33(1):84-9. PubMed ID: 15651719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CPT-11 in human colon-cancer cell lines and xenografts: characterization of cellular sensitivity determinants.
    Jansen WJ; Zwart B; Hulscher ST; Giaccone G; Pinedo HM; Boven E
    Int J Cancer; 1997 Jan; 70(3):335-40. PubMed ID: 9033637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor activity of IHL-305, a novel pegylated liposome containing irinotecan, in human xenograft models.
    Matsuzaki T; Takagi A; Furuta T; Ueno S; Kurita A; Nohara G; Kodaira H; Sawada S; Hashimoto S
    Oncol Rep; 2012 Jan; 27(1):189-97. PubMed ID: 21935577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor activity of a novel quinoline derivative, TAS-103, with inhibitory effects on topoisomerases I and II.
    Utsugi T; Aoyagi K; Asao T; Okazaki S; Aoyagi Y; Sano M; Wierzba K; Yamada Y
    Jpn J Cancer Res; 1997 Oct; 88(10):992-1002. PubMed ID: 9414662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of the clinical experience with irinotecan (CPT-11).
    Horowitz RW; Wadler S; Wiernik PH
    Am J Ther; 1997; 4(5-6):203-10. PubMed ID: 10423612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial growth factor expression is closely related to irinotecan-mediated inhibition of tumor growth and angiogenesis in neuroblastoma xenografts.
    Kaneko S; Ishibashi M; Kaneko M
    Cancer Sci; 2008 Jun; 99(6):1209-17. PubMed ID: 18384433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of central nervous system xenografts with camptothecins.
    Friedman HS; Houghton PJ
    Ann N Y Acad Sci; 1996 Dec; 803():210-2. PubMed ID: 8993514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.